Oral Composition for Reducing Human Microplastics Accumulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Microplastics have been found in human bodies, leading to adverse health effects in animal models and cytotoxicity in human cells, necessitating methods to reduce their levels and accumulation rates.
Innovation Solution
A composition comprising an iron (II) compound, soluble fiber, fruit or vegetable phytochemical, turmeric or ginger extract, omega-3 compound, alga, and lycopene is administered orally to reduce microplastics levels and accumulation rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If microplastics are present in the environment and enter human bodies, then environmental contamination occurs, but adverse health effects and cytotoxicity result
Solution Approach 1:
The patent applies this principle by using activated carbon, which is known for its adsorption properties, to bind and remove microplastics from the body. The harmful microplastics are converted into a removable complex through adsorption, transforming the harmful exposure into a treatable condition. The composition converts the harmful presence of microplastics into a benefit by providing a mechanism for their active removal through the adsorptive action of activated carbon and other components.
2Quantity of substance
If microplastics accumulate in human bodies, then environmental contamination increases, but health risks and cytotoxicity increase
Solution Approach 1:
The patent applies this principle by extracting microplastics from the body through the administered composition. The activated carbon and other components selectively bind to microplastics, allowing them to be extracted from bodily fluids and tissues. This extraction process removes the harmful substance (microplastics) from the system, directly addressing the accumulation problem and reducing associated health risks.
Solution Approach 2:
The patent uses activated carbon and other composition components as intermediaries to facilitate the removal of microplastics. These substances act as mediators that bind to microplastics, enabling their transport and elimination from the body. The intermediary substances bridge the gap between the harmful microplastics and the body's natural elimination processes, making removal possible without directly confronting the microplastics themselves.
3Measurement precision
If microplastics are found in human bodies, then environmental pollution is confirmed, but conclusive health impact studies are lacking
Solution Approach 1:
The patent applies this principle by providing a preventive and therapeutic intervention before conclusive harm is established. The composition is designed to remove microplastics proactively, preventing potential health issues before they manifest. This preliminary action allows for treatment based on detected presence rather than waiting for confirmed damage, addressing the uncertainty in health impact assessment by taking preventive measures.
Data Source
AI summary
Described herein is a method for reducing microplastic levels or reducing or minimizing microplastic accumulation rates in a subject, such as a human. The method includes administering to the subject orally an effective amount of a composition including: an iron (II) compound; a soluble fiber; a fruit or vegetable phytochemical; a turmeric powder or extract; a ginger powder or extract; an omega 3 compound; an alga; and lycopene. Also described herein is a kit for carrying out the methods described herein.